Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3... by Matasar, Matthew J, MD, Capra, Marcelo, MD, Özcan, Muhit, Prof, Lv, Fangfang, MD, Li, Wei, Prof, Yañez, Eduardo, MD, Sapunarova, Katya, PhD, Lin, Tongyu, Prof, Jin, Jie, Prof, Jurczak, Wojciech, Prof, Hamed, Aryan, MD, Wang, Ming-Chung, MD, Baker, Ross, Prof, Bondarenko, Igor, Prof, Zhang, Qingyuan, Prof, Feng, Jifeng, Prof, Geissler, Klaus, Prof, Lazaroiu, Mihaela, MD, Saydam, Guray, Prof, Szomor, Árpád, MD, Bouabdallah, Krimo, MD, Galiulin, Rinat, MD, Uchida, Toshiki, MD, Soler, Lidia Mongay, MD, Cao, Anjun, PhD, Hiemeyer, Florian, MSc, Mehra, Aruna, MD, Childs, Barrett H, MD, Shi, Yuankai, Prof, Zinzani, Pier Luigi, Prof

Get full text